{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:22:24Z","timestamp":1761895344173},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,9,9]],"date-time":"2011-09-09T00:00:00Z","timestamp":1315526400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s11239-011-0636-z","type":"journal-article","created":{"date-parts":[[2011,9,8]],"date-time":"2011-09-08T09:42:13Z","timestamp":1315474933000},"page":"197-201","source":"Crossref","is-referenced-by-count":2,"title":["Thrombotic complications in multiple myeloma: a report of three cases and review of the literature"],"prefix":"10.1007","volume":"33","author":[{"given":"Yonal","family":"Ipek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hindilerden","family":"Fehmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Besisik-Kalayoglu","family":"Sevgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sargin","family":"Deniz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,9,9]]},"reference":[{"key":"636_CR1","first-page":"125","volume":"10","author":"H Lackner","year":"1973","unstructured":"Lackner H (1973) Hemostatic abnormalities associated with dysproteinemias. Semin Hematol 10:125\u2013133","journal-title":"Semin Hematol"},{"key":"636_CR2","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/bmj.3.5720.438","volume":"3","author":"D Catovsky","year":"1970","unstructured":"Catovsky D, Ikoku NB, Pitney WR et al (1970) Thromboembolic complications in myelomatosis. Br Med J 3:438\u2013439","journal-title":"Br Med J"},{"key":"636_CR3","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/BF02994017","volume":"73","author":"A Shinagawa","year":"2001","unstructured":"Shinagawa A, Kojima H, Kobayashi T et al (2001) Lupus anticoagulant-like activity observed in a dimeric lambda protein produced by myeloma cells. Int J Hematol 73:526\u2013531","journal-title":"Int J Hematol"},{"key":"636_CR4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/(SICI)1096-8652(199910)62:2<99::AID-AJH6>3.0.CO;2-N","volume":"62","author":"Z Yasin","year":"1999","unstructured":"Yasin Z, Quick D, Thiagarajan P et al (1999) Light-chain paraproteins with lupus anticoagulant activity. Am J Hematol 62:99\u2013102","journal-title":"Am J Hematol"},{"key":"636_CR5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/(SICI)1096-8652(199604)51:4<319::AID-AJH12>3.0.CO;2-9","volume":"51","author":"SR Deitcher","year":"1996","unstructured":"Deitcher SR, Erban JK, Limentani SA (1996) Acquired free protein S deficiency associated with multiple myeloma: a case report. Am J Hematol 51:319\u2013323","journal-title":"Am J Hematol"},{"key":"636_CR6","first-page":"114","volume":"80","author":"A D\u2019Angelo","year":"1995","unstructured":"D\u2019Angelo A, Mazzola G, Bergmann F et al (1995) Autoimmune protein S deficiency: a disorder predisposing to thrombosis. Haematologica 80:114\u2013121","journal-title":"Haematologica"},{"key":"636_CR7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00001721-200204000-00003","volume":"13","author":"M Zangari","year":"2002","unstructured":"Zangari M, Saghafifar F, Anaissie E et al (2002) Activated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications. Blood Coagul Fibrinolysis 13:187\u2013192","journal-title":"Blood Coagul Fibrinolysis"},{"key":"636_CR8","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1055\/s-0038-1647509","volume":"59","author":"PE Gargan","year":"1988","unstructured":"Gargan PE, Ploplis VA, Scheu JD (1988) A fibrin specific monoclonal antibody which interferes with the fibrinolytic effect of tissue plasminogen activator. Thromb Haemost 59:426\u2013431","journal-title":"Thromb Haemost"},{"issue":"10","key":"636_CR9","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/annonc\/mdh385","volume":"15","author":"S Sallah","year":"2004","unstructured":"Sallah S, Husain A, Wan J, Vos P, Nguyen NP (2004) The risk of venous thromboembolic disease in patients with monoclonal gammopathy of undetermined significance. Ann Oncol 15(10):1490\u20131494","journal-title":"Ann Oncol"},{"issue":"3","key":"636_CR10","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/cncr.20405","volume":"101","author":"G Srkalovic","year":"2004","unstructured":"Srkalovic G, Cameron MG, Rybicki L, Deitcher SR, Kattke-Marchant K, Hussein MA (2004) Monoclonal gammopathy of undetermined significance and multiple myeloma are associated with an increased incidence of venothromboembolic disease. Cancer 101(3):558\u2013566","journal-title":"Cancer"},{"issue":"3","key":"636_CR11","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.thromres.2009.01.004","volume":"125","author":"AL Cohen","year":"2009","unstructured":"Cohen AL, Sarid R (2009) The relationship between monoclonal gammopathy of undetermined significance and venous thromboembolic disease. Thromb Res 125(3):216\u2013219","journal-title":"Thromb Res"},{"issue":"24","key":"636_CR12","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1182\/blood-2009-11-252072","volume":"115","author":"SY Kristinsson","year":"2010","unstructured":"Kristinsson SY, Pfeiffer RM, Bj\u00f6rkholm M, Goldin LR, Schulman S, Blimark C, Mellqvist UH, Wahlin A, Turesson I, Landgren O (2010) Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study. Blood 115(24):4991\u20134998","journal-title":"Blood"},{"issue":"9","key":"636_CR13","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1182\/blood-2008-04-151076","volume":"112","author":"SY Kristinsson","year":"2008","unstructured":"Kristinsson SY, Fears TR, Gridley G et al (2008) Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma. Blood 112(9):3582\u20133586","journal-title":"Blood"},{"issue":"6","key":"636_CR14","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/blood-2007-10-078022","volume":"111","author":"RA Kyle","year":"2008","unstructured":"Kyle RA, Rajkumar SV (2008) Multiple myeloma. Blood 111(6):2962\u20132972 Mar 15","journal-title":"Blood"},{"key":"636_CR15","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1200\/JCO.2009.22.8197","volume":"27","author":"A Falanga","year":"2009","unstructured":"Falanga A, Marchetti M (2009) Venous thromboembolism in the hematologic malignancies. J Clin Oncol 27:4848\u20134857","journal-title":"J Clin Oncol"},{"key":"636_CR16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2141.2008.07577.x","volume":"145","author":"C Eby","year":"2009","unstructured":"Eby C (2009) Pathogenesis and management of bleeding and thrombosis in plasma cell dyscrasias. Br J Haematol 145:151\u2013163","journal-title":"Br J Haematol"},{"key":"636_CR17","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.leukres.2007.12.002","volume":"32","author":"AM Marion van","year":"2008","unstructured":"van Marion AM, Auwerda JJ, Lisman T et al (2008) Prospective evaluation of coagulopathy in multiple myeloma patients before, during and after various chemotherapeutic regimens. Leuk Res 32:1078\u20131084","journal-title":"Leuk Res"},{"key":"636_CR18","first-page":"3349","volume":"7","author":"J Fujita","year":"2001","unstructured":"Fujita J, Mestre JR, Zeldis JB, Subbaramaiah K, Dannenberg AJ (2001) Thalidomide and its analogues inhibit lipopolysaccharide mediated induction of cyclooxygenase-2. Clin Cancer Res 7:3349\u20133355","journal-title":"Clin Cancer Res"},{"key":"636_CR19","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1182\/blood-2008-02-140434","volume":"112","author":"DC Johnson","year":"2008","unstructured":"Johnson DC, Corthals S, Ramos C et al (2008) Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping. Blood 112:4924\u20134934","journal-title":"Blood"},{"key":"636_CR20","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1182\/asheducation-2010.1.437","volume":"2010","author":"SY Kristinsson","year":"2010","unstructured":"Kristinsson SY (2010) Thrombosis in multiple myeloma. Hematol Am Soc Hematol Educ Progr 2010:437\u2013444","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"issue":"5","key":"636_CR21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/MBC.0b013e32832b27e6","volume":"20","author":"GP Talamo","year":"2009","unstructured":"Talamo GP, Ibrahim S, Claxton D, Tricot GJ, Fink LM, Zangari M (2009) Hypercoagulable states in patients with multiple myeloma can affect the thalidomide-associated venous thromboembolism. Blood Coagul Fibrinolysis 20(5):337\u2013339","journal-title":"Blood Coagul Fibrinolysis"},{"key":"636_CR22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-2007-976169","volume":"33","author":"M Zangari","year":"2007","unstructured":"Zangari M, Elice F, Fink L, Tricot G (2007) Hemostatic dysfunction in paraproteinemias. Semin Thromb Hemost 33:339\u2013349","journal-title":"Semin Thromb Hemost"},{"key":"636_CR23","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/(SICI)1096-8652(199604)51:4<319::AID-AJH12>3.0.CO;2-9","volume":"51","author":"S Deitcher","year":"1999","unstructured":"Deitcher S, Erban J, Limentani S (1999) Acquired free protein S deficiency associated with multiple myeloma: a case report. Am J Hematol 51:319\u2013323","journal-title":"Am J Hematol"},{"key":"636_CR24","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0049-3848(86)90221-5","volume":"42","author":"A Gruber","year":"1986","unstructured":"Gruber A, Blasko G, Sas G (1986) Functional deficiency of protein C and skin necrosis in multiple myeloma. Thromb Res 42:579\u2013581","journal-title":"Thromb Res"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-011-0636-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-011-0636-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-011-0636-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T04:19:48Z","timestamp":1560572388000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-011-0636-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,9]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["636"],"URL":"https:\/\/doi.org\/10.1007\/s11239-011-0636-z","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,9]]}}}